Page 20 - Commercial Underwriting Mandates & Guidelines Binder Addendum

4.7 4.8
4.9 4.10
Fines, Penalties, Vindictive, punitive and/or exemplary damages.
Product Liability coverage for manufacturers of tobacco/tobacco products.
Tobacco Manufacturer Products Liability Exclusion
Other than manufacturers of cigarette paper or filters the product liability of manufacturers of tobacco and tobacco products and companies that are liable as a manufacturer of tobacco and tobacco products (e.g. retailer with own brand) are excluded.
Performance Guarantees. Pharmaceutical Exclusion list
This Contract shall not cover claims arising from the production sale or provision of the following:
4.10.1 4.10.2 4.10.3 4.10.4 4.10.5
4.10.6 4.10.7 4.10.8 4.10.9 4.10.10 4.10.11 4.10.12
4.10.13 4.10.14 4.10.15 4.10.16 4.10.17 4.10.18 4.10.19 4.10.20 4.10.21 4.10.22 4.10.23 4.10.24 4.10.25 4.10.26 4.10.27 4.10.28 4.10.29 4.10.30
Blood Borne Pathogens
Canthaxathin
Cerivastatin and/or any other statins and/or fibrates
Cisapride
Contraceptives (including birth control pills) fertility drugs and Products specifically designed and marketed for use during and in connection with pregnancy
Danthron
Debendox
Dexfenfluramine (Redux)
Dicyclomine when given to children under 4 years of age
Diethylstilbestrol
Dioxins
Ephedrine Ma Huang Chinese Ephedra Mahuang Extract Sinica Ephedra Extract Ephedra Herb Powder Epitonin or any derivative thereof
Fenfluramine (Pondimin)
Germanium
Halogenated 8 and Hydroxy Quinolines
Hydroquinone
Methylphenidate
Pertussis vaccine
Phenfluramine (Fen-Phen)
Phenylpropanolamine (PPA)
Primodos/Amenorone Forte
Prozac or Fluexetine
Remicade
Skin whitening or lightening agents
Swine-Flu Vaccine
Thalidomide
Thimerosa/Thiomersal
Tretinoin (retinoic acid or its salts) including Isotretinoin (Accutane) or any derivative thereof
Tryptophan
Any Product caused or failing to cure or alleviate any condition directly or indirectly caused by or associated with:
4.10.30.1 Hepatitis
4.10.30.2 Human T-Cell Lymphotropic Virus Type iii (HTLViii) or Lymphadenopathy Associated Virus (LAV) or the mutants derivatives or variations thereof or in any way related to Acquired Immune Deficiency Syndrome or any syndrome or condition of a similar kind howsoever it shall be named
Annexure A: Treaty Exclusions
17
Commercial Underwriting Mandates & Guidelines Addendum – Binder – Version 4 2022